Catheter Precision, Inc. (VTAK) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Catheter Precision, Inc. on May 21, 2024, covering events occurring on May 15, 2024. The Company is incorporated in Delaware and its common stock trades on the NYSE American under the symbol VTAK.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
On May 15, 2024, John P. Francis informed the Board of Directors that he would not stand for reelection at the 2024 Annual Meeting of Stockholders scheduled for July 3, 2024. His term as a director will expire at that meeting. The Company stated there is no disagreement between Mr. Francis and the Company regarding operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook. No specific risks or contingencies were disclosed beyond the standard departure of a director.
Key Facts for Investor Verification
- John P. Francis will not seek reelection to the Board of Directors.
- Mr. Francis's director term expires at the Annual Meeting on July 3, 2024.
- The departure is not due to any disagreement with the Company.
- The report was signed by Margrit Thomassen, Interim Chief Financial Officer.